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BAFeIII can also affect reductive dechlorination in MNA and EAB applications. BAFeIII can result in TCE being reductively dechlorinated to cDCE only and further reductive dechlorination can be inhibited (AFCEE, 2004) . Thus knowledge of the BAFeIII concentration can indicate the potential for incomplete reductive dechlorination of TCE. It can also be used for planning EAB remedies. If the BAFeIII concentration is sufficient to inhibit cDCE reductive dechlorination, reductive dechlorination of TCE to cDCE and VC followed by oxidative biodegradation of VC and possibly cDCE under iron-reducing conditions may be a better approach.
Objectives of the Demonstration
The overall objective of this project was to demonstrate and validate the performance of the BAFeIII assay as an analytical technology for use in supporting bioremediation. Specific objectives were to:
Validate the BAFeIII assay method using a combination of confirmatory analyses conducted by the U.S. EPA (EPA/Ada and EPA/Athens), Georgia Institute of Technology, and University of Colorado. Quantify costs associated with the technology.
Regulatory Drivers
Analysis of BAFeIII is not required at this time and is considered optional by regulatory agencies. Additionally, no method for BAFeIII has been approved by the EPA since it does not approve methods for unregulated compounds. The analyte (BAFeIII) of interest in this demonstration is discussed in the EPA technical guidance on monitored natural attenuation (MNA) and enhanced anaerobic bioremediation (EAB) of chlorinated solvents (U.S. EPA, 1998; AFCEE, 2004) . These documents review the use of BAFeIII data to assess MNA of organic contaminants such as VC and consumption of injected electron donors during EAB. 
Demonstration Results

Stakeholder/End-User Issues
The BAFeIII assay is an important tool that allows remedial project managers to obtain a more accurate and complete picture of site geochemistry and microbiology. This tool is useful in bioremediation projects involving natural attenuation and enhanced anaerobic bioremediation. Use of the direct BAFeIII assay is recommended as a replacement for indirect chemical extraction methods. Additionally, it is recommended that BAFeIII analysis of soil be conducted in addition to ferrous iron analysis in groundwater. The BAFe III assay purchase cost ranges from $50 to $75 each depending on the quantity purchased. Additional equipment, supplies, and labor are required and the estimated analysis cost was calculated to be $212 each based on analysis of 6 samples. BAFeIII analysis conducted by a commercial laboratory has been quoted at $250 per analysis.
Technology Description
Technology Development and Application
The BAFeIII test kit is pictured in Figure 2- The BAFeIII assay can be used for site characterization and monitoring in MNA and EAB applications. Natural attenuation of benzene-toluene-ethylbenzene-xylenes (BTEX) is one common example. Initial site characterization for MNA involves the calculation of assimilative capacity of an aquifer for biodegradation of BTEX. The BAFeIII assay can be used to estimate the assimilative capacity in the aquifer material for BTEX biodegradation. These results can be used to determine the mass of BTEX that has been degraded previously and the potential for future BTEX biodegradation. (Evans and Koenigsberg, 2001) . BAFeIII can result in TCE being reductively dechlorinated to cDCE only and further reductive dechlorination can be inhibited (AFCEE, 2004) . Thus knowledge of the BAFeIII concentration can indicate the potential for incomplete reductive dechlorination of TCE. It can also be used for planning EAB remedies. If the BAFeIII concentration is sufficient to inhibit cDCE reductive dechlorination, reductive dechlorination of TCE to cDCE and VC followed by oxidative biodegradation of VC and possibly cDCE under iron-reducing conditions may be a better approach.
A challenge in applying BAFeIII results is that insufficient experience exists to use the results in quantitative models at this time. Nevertheless, the results from the assay can be used in either a quantitative or qualitative manner. The BTEX example above represents a quantitative application of BAFeIII assay results. The enhanced anaerobic bioremediation application represents a qualitative application of the assay. Experience using the assay results in a qualitative fashion will lead to more quantitative applications as a database is developed. An example of a potential application is incorporation of BAFeIII as a variable in biodegradation computer modeling programs such as the EPA program BIOPLUME IV which is currently being beta-tested (John Wilson, personal communication) . BIOPLUME is a two-dimensional, finite difference model for simulating the natural attenuation of organic contaminants in groundwater due to the processes of advection, dispersion, sorption, and biodegradation. The BIOPLUME program uses an USGS solute transport code and kinetic equations to determine the fate and transport of the organic contaminants and the electron acceptors (dissolve oxygen, nitrate, BAFeIII, sulfate, and carbon dioxide) and the reaction by-products (including dissolved Fe II). BioRedox-MT3DMS is another numerical fate and transport model that includes BAFeIII as an input parameter (Thompson et al. 2004 ).
Process Description
The procedure for the BAFeIII assay is graphically illustrated in Figure 2 -2 and includes the following steps following homogenization:
• Two 5-gram samples are placed into each of two 25-mL assay tubes labeled T 0 and T 30 .
• The T 0 tube, which is used to determine the initial or ambient concentration of Fe II present in the soil immediately following sample collection, contains no reagents or BrY, is filled with distilled water and 1 mL concentrated HCl, capped, then placed on a tube rotator for 48 hours, during which time weakly associated Fe II is extracted from the soil.
• Following the extraction period, the T 0 extract liquid is filtered, if necessary, and analyzed for initial Fe II.
• The T 30 tube is filled with distilled water plus the assay reagents, capped, mixed by hand, and then incubated in the dark at room temperature for 30 days. During the incubation period the iron-reducing bacteria (i.e., BrY) consume lactate and reduce BAFeIII to Fe II.
• Following the incubation period, 1 mL of liquid is withdrawn from the T 30 tube, discarded, replaced with 1 mL concentrated HCl to create a 0.5N HCl solution, then the tube is placed on a tube rotator for 48 hours, during which time both initial Fe II and Fe II produced by BAFe III reduction are solubilized.
• Following the extraction period, the T 30 liquid is filtered and analyzed for Fe II.
• The concentration of Fe II in the T 30 extract liquid is the total Fe II -the sum of ambient Fe II (T 0 tube) and BAFeIII. The following formula is used to calculate BAFeIII:
C E is the measured concentration of Fe II in the extract liquid (mg/L) and F S is the solids fraction (g dry soil/g wet soil).
• Extract Fe II concentrations (C E ) are measured using a Hach test kit (Hach Company, 
Previous Testing of the Technology
Initial development and preliminary field-testing of the BAFeIII assay technology was conducted under a Phase I Small Business Innovative Research (SBIR) grant from the USAF (Evans, 1997; Evans, 2000) . Further development and field-testing of the technology was conducted under Phase II of the SBIR, which led to development of a field test kit .
Advantages and Limitations of the Technology
Advantages and limitations of the BAFeIII assay are summarized in Table 2 -1. These advantages are described in detail below. Bacteria must be stored frozen prior to use.
Facultative bacterium is used that does not need to be stored anaerobically.
Uses Shewanella alga BrY which may not be representative of all sites.
Analytical
Methodology
Assay composition and method has been standardized.
30-day incubation time.
Frequent sampling is not necessary. Requires soil or sediment samples and invasive sampling for their procurement.
Sampling Requirements
Requires 5 grams of soil per analysis. Indicates BAFeIII electron donor demand for MNA and EAB applications.
No reference method for BAFeIII analysis exists.
Technology Application
Analysis is more robust than commonly used chemical extraction methods.
Can give maximum values for BAFeIII because of presence of electron shuttles in assay reagent.
BAFeIII data allow site managers and regulators to evaluate MNA and EAB at sites more completely and accurately than with dissolved Fe II data alone. In the case of BTEX natural attenuation, dissolved Fe II data allow calculation of the mass of BTEX that has been biodegraded historically and is being biodegraded currently. BAFeIII data allow calculation of the mass of BTEX that will be biodegraded in the future. It is impossible to calculate future potential for BTEX biodegradation using dissolved Fe II data alone. Furthermore, since most dissolved Fe II remains bound to the soil, the historical and current mass of biodegraded BTEX is underestimated using dissolved Fe II data for electron acceptor calculations. Completion of a mass balance and subsequent understanding of contaminant source fate is dependent on accurate electron acceptor calculations. In the case of EAB of TCE, BAFeIII data allow determination of the total electron donor demand. High electron donor demand can decrease the likelihood that TCE will be reductively dechlorinated beyond cDCE to VC and ethene upon addition of an electron donor such as molasses, lactic acid, vegetable oil, or HRC TM (Evans and Koenigsberg, 2001; AFCEE, 2004) . High electron donor demand can also prevent complete reductive dechlorination under MNA conditions. Dissolved Fe II data alone give no indication of this electron donor demand.
While the BAFeIII assay provides these advantages over measurement of dissolved Fe II, it does depend on soil sampling in the saturated zone, which is costly and inconvenient for routine sampling. On the other hand, measurement of BAFeIII in soil likely does not require quarterly sampling of numerous locations. This decreased sampling frequency can minimize the additional cost associated with soil sample collection.
The BAFeIII assay evaluated in this report is in a sense a standardized bioassay. Besides being the first of its kind, the assay has many advantages that make it an easy-to-use and reliable analytical tool. Unlike laboratory-based microcosm studies, it is standardized, self-contained, portable, packaged for field or laboratory use, and includes lyophilized FeRB that are relatively stable. Care must be taken to store the lyophilized FeRB under freezing conditions for stability. The bioassay reagents other than FeRB are packaged separately from the FeRB and are stable at room temperature. These chemical components are present at optimal levels and are known to influence bioavailability. Their presence is intended to provide reproducible, standardized, and direct estimates of the maximum concentration of BAFeIII in a given soil sample. Recognition that the assay results are maximum values should be considered when using the data. For example, the amount of electron donor required to overcome iron reduction alone in an enhanced anaerobic bioremediation scenario may be less than predicted based on BAFeIII assay results.
A potential limitation of the BAFeIII assay is that the indigenous FeRB may be different in their iron-reducing capabilities when compared to the strain used in the assay (i.e., Shewanella alga BrY). Inclusion of BrY in the assay was intended to make the assay standardized and reproducible. Additionally, since BrY is a facultative microorganism, storage under anaerobic conditions is not necessary, further increasing the test kit's ease-of-use. BAFeIII is an operationally defined analyte (i.e., the measured value of the analyte is dependent on the method used for its analysis) and use of BrY is part of this operational definition. The BrY-based assay yields a reproducible maximum value of BAFeIII in a given sample. The decision whether or not to use BrY in the bioassay represents a trade-off of obtaining site-specific results versus standardization, reproducibility, and ease-of-use. If results using only indigenous bacteria are desired, the BrY culture can easily be left out of the assay since it is packaged separately. Iron reduction would then be accomplished via FeRB that are indigenous to the soil sample used in the assay. A new limitation would be introduced by conducting the assay in this manner, however, since the required incubation time would be unknown. Monitoring of the assay over time would be required which would decrease the ease-of-use of the assay. Direct comparison of BAFeIII results to results for other sites would also not be possible. In addition to BrY, electron shuttles (i.e., humic acids and AQDS) are included in the assay. The inclusion of electron shuttles is also part of the operational definition. Their inclusion increases the reliability and speed of the assay and also can result in determination of maximum BAFeIII values.
Another potential limitation of the BAFeIII assay involves the one-month incubation time. However, considering that standard turnaround time for most analytical laboratories is two weeks, this time requirement is acceptable in most cases.
Finally, no standardized technologies exist for directly measuring BAFeIII. Other methods that have been used or evaluated for BAFeIII measurement are presented in Table 2 -2 and discussed below. Chemical extraction, sophisticated instrument-dependent methods, and microcosm studies have been evaluated, but each has significant disadvantages. Selective extraction using a variety of extractants, including various concentrations of HCl, hydroxylamine-HCl, ammonium oxalate, citrate, citrate dithionite bicarbonate and other compounds has been used to attempt to quantify BAFeIII. However, these extractants do not provide direct measurements and do not necessarily correlate to the concentration of BAFeIII (Lovley and Phillips, 1987) . Also, extraction methods do not take into account the effect of groundwater chemistry on bioavailability. A laboratory method for BAFeIII quantitation involving redox titration of soil with the reduced form of anthraquinone disulfonate (AQDS) also known as anthraquinol disulfonate (AHDS) has been evaluated (Hacherl et al., 2001 ). This method is not readily available. Sophisticated instrumentation, including electron microscopy, electron microprobe analysis, near infrared spectrophotometry, and Mössbauer spectroscopy have been evaluated but are not especially useful. Furthermore, these techniques are expensive and not readily available. Microcosm studies have been conducted in various laboratories but with different methods and media.
While microcosm studies are a direct approach to evaluation of BAFeIII, no standard method exists for conducting them; they are also time-consuming and expensive. Therefore, the major advantage of the BAFeIII assay over other methods is that it is a standardized and direct measurement of BAFeIII.
Demonstration Design
Performance Objectives
The BAFeIII assay is difficult to validate because no standard method exists to measure bioavailability of ferric iron. Nevertheless, performance criteria were developed a priori in order to be able to validate the BAFeIII assay. These criteria were based initially on the demonstrated relationship between Fe III bioavailability and Fe III oxide particle surface area (Roden and Zachara, 1996) . Different Fe III oxides ranging from amorphous ferric oxyhydroxide to various crystalline forms have different specific surface areas. Oxides with greater specific surface area (amorphous oxides having the greatest) have been shown to be more bioavailable for iron reduction (Roden and Zachara, 1996) . Thus the initial working hypothesis of the evaluation was that the BAFeIII concentration determined by the assay should correlate to the specific surface area of the oxide particles in a soil sample. In addition, other factors associated with groundwater may influence Fe III bioavailability (Evans, 2000; Roden and Urrutia, 2002) including pH, specific conductivity, divalent cations, electron shuttles such as humic acids, chelators, and adsorbed anions including ferrous iron. Performance objectives for the demonstration were based in part on these multiple factors and are presented in Relationship between BAFeIII assay and degree of iron oxide crystallinity/surface area.
Positive association Yes
Relationship between BAFeIII assay and confirmatory analyses.
Range 
SUBASE Bangor
The study area for this demonstration is the vicinity of Operable Unit 8 (OU8), located in the Public Works Industrial Area (PWIA) of SUBASE Bangor. SUBASE Bangor is located near the town of Silverdale, Washington. An onsite UST is believed to be the source of a release of unleaded gasoline into the surrounding media between 1982 and 1986. In 1986, soil vapor extraction/air system and product recovery were implemented to clean up the site. To date, liquid petroleum hydrocarbons remain in several monitoring wells at the PWIA (EA, 2000) . Chlorinated VOCs are also present in site groundwater (EA, 2000) . 
Fort Lewis
The study area for this demonstration is the vicinity of the East Gate Disposal Yard (EGDY) of the Fort Lewis Logistics Center (Fort Lewis), located south of Tacoma, Washington. The EGDY, which is situated at the northwest corner of the base, originally was used for storage and disposal of various solid and liquid waste products. Since 1982, studies have been conducted at the EGDY to verify and delineate contamination at the site. Affected media were soil and groundwater, with the prominent contaminant being trichloroethene (TCE) (Battelle, 2000) .
The upper portion of the EGDY at Fort Lewis consists of a brown to black alluvial sand and gravel matrix with local lenses of silts. The material gets coarse with depth. Underlying this formation at about 260 feet msl is the Vashon Till, which is a complex mixture of silt, sand, and clay. The Vashon Till has low permeability and serves as a barrier between the upper and deeper aquifers. At the source area the groundwater can be encountered between 8 and 15 feet bgs. Farther downgradient the groundwater is generally between 10 and 35 feet bgs. The upper aquifer is unconfined and mostly anaerobic. Groundwater flow is generally west to northwest. There are more than 80 monitoring wells and piezometers on site.
Battelle Memorial Institute (in cooperation with the Air Force Research Laboratory, USGS, EPA, and Cornell University) performed Reductive Anaerobic In Situ Treatment Technology (RABITT) at the EGDY of Fort Lewis, and further site characterization details can be found in their report (Battelle, 2000) . The BAFeIII demonstration was done in the vicinity of the RABITT demonstration.
NAS Pensacola
The study area for this demonstration is the vicinity of the wastewater treatment plant at the NAS in Pensacola, Florida (NAS Pensacola), located near Pensacola Bay in the far northwest corner of the state (USGS, 1999).
The area predominantly consists of marine and fluvial terrace deposits ranging from fine-to medium-grained sands, silts, clays, and gravel. The site has two aquifers, a shallow aquifer and a deeper confined aquifer (referred to as the underlying main producing zone). There is a 20-footthick confining barrier of low-permeable silts and clays that separate the upper and lower aquifers. The upper aquifer is composed of fine-to medium-grained sands. The main producing zone is used locally as a water supply and consists of permeable sands and gravel. Two plumes have been identified at the site, one comprised of chlorinated ethenes and the other chlorinated benzenes. Most of the contaminants on site are located in the upper aquifer region. The depth of contamination ranges from 20 to 40 feet bgs.
Elizabeth City
The U.S. Coast Guard Support Center in Elizabeth City, North Carolina, is located on the southern bank of the Pasquotank River. Two separate areas at the site were used in this demonstration, the fuel farm area (petroleum hydrocarbon) and the North Beach area (chlorinated VOCs).
The following description of the fuel farm area was obtained from the report by Wilson, et al. (2000) . The former fuel farm was located south of a concrete ramp used to recover seaplanes from the Pasquotank River. A plume of MTBE and fuel hydrocarbons in ground water emanates from a source area in the location of the former fuel farm, and flows under the concrete ramp toward the Pasquotank River to the north, and toward a drainage canal along the western side of the seaplane ramp. This source area corresponds to the former location of fuel storage tanks on the site. Fuel was stored at the site until December 31, 1991. The fuel farm had been in use since 1942, and originally consisted of a 50,000-gallon concrete underground storage tank and two steel underground storage tanks with a volume of 12,000-gallons and 15,000-gallons, respectively. The steel tanks were apparently removed in the mid-1980s. In addition to the underground storage tanks, two steel, aboveground storage tanks with a capacity of 50,000 gallons were installed in the mid-1980s. There was evidence of corrosion in the transfer lines from these tanks. They were taken out of service and removed from the site. No evidence of a release from the pipes was discovered. The U.S. Coast Guard began a free product recovery effort at the site in September 1990. Eight recovery wells were arranged around the source area in a circle. By March 1992, a total of 79,000 gallons of fuel was recovered. 
The following description of the North Beach Disposal Area was provided by ARCADIS (2004
, a food-grade polylactate ester, was injected into the shallow aquifer zone at multiple points near Source Area 2 of the North Beach Disposal Area from January 21 to 25, 2003. The treatment area for HRC injection is a grid approximately 40 feet wide by 100 feet long, encompassing Monitor Wells GP20, GM315, GM330, and GM360. Within the grid area, Standard HRC was injected into 40 points while HRC Primer was injected into 9 points. A total of 5,545 pounds of HRC was injected across the grid, with between 110 and 135 pounds of Standard HRC or primer injected at each point. The depths for these injections were 5 feet below ground surface (ft bgs) to 45 ft bls within the primary interval impacted by chlorinated VOCs. Quarterly monitoring has been conducted for one year since the HRC injections. Results indicate that HRC does not appear to have significant influence on groundwater geochemistry beyond the immediate vicinity of the injection points within the grid.
Physical Set-up and Operations
On-site operations involved collection and packaging of samples as described in Section 3.5. Site visits were conducted as follows: Physical operation and set-up of the BAFeIII test kit was conducted as described in Section 2.2.
Sampling/Monitoring Procedures
Groundwater samples were collected from existing monitoring wells on each site using low flow techniques and a peristaltic or bladder pump system. Soil borings were completed for collection of soil samples using hollow-stem auger, direct push technology, or hand-auger. During drilling, a CDM engineer or scientist logged and sampled the borings. The soils were visually described and classified in accordance with the Unified Soil Classification System (USCS; ASTM D2488-84). Generally two sections of each boring were collected (i.e., the top and bottom portions). Specific sample locations and depths are presented in the Final Report (NAVFAC, 2005) . Attempts were made to obtain different types of soil samples as defined by USCS. The soil from each section was homogenized by hand (mixing with stainless steel spoon in a bowl) and then placed in 4-or 8-ounce glass jars, capped with Teflon TM -lined lids, and labeled prior to shipment to the labs. Samples were shipped in coolers with ice to maintain temperature between 2 and 6 o C. Soil samples were sent to the CDM laboratory in Bellevue, Washington for BAFeIII analysis. Soil samples were also sent to other organizations for analysis as detailed in 
Performance Data
This section presents a brief summary of performance data for the BAFeIII assay. A more complete description of these data is presented in the Final Report (NAVFAC, 2005) .
Replicate analyses were conducted to demonstrate the intra-laboratory precision of the BAFeIII assay. An absolute RPD of 35 was used to evaluate the replicate data. This value was selected as an approximate criterion for analyses of replicates of inherently non-homogeneous soils.
Further discussion of the valid use of an RPD of 35 can be found in EPA guidance on analysis of solid matrices (U.S. EPA, 2002) . The overall average absolute RPD for the 76 CDM intralaboratory replicates was 29.7, which met the RPD ≤ 35 criterion, with absolute RPDs for most of the individual replicates (77.6%) also meeting the criterion (Figure 4-1) . Replicate analyses were also conducted to demonstrate the inter-laboratory precision of the BAFeIII assay. An RPD of 0 was used to evaluate the replicate data. This value was selected to represent no difference between the analyses as conducted by the two laboratories, i.e., a perfect 1:1 correlation and no inter-laboratory bias. The overall average RPD for the 40 inter-laboratory replicates was 12, which indicated that the CDM results were slightly higher, on average, than the EPA results (Figure 4-2) but the difference was not statistically significant. The correlation coefficient for the log-transformed data was 0.98. For the aquifer samples, 25% of the samples agreed within a factor of 20%, 50% agreed within a factor of 37%, 75% agreed within a factor of 66%, and all of the samples agreed within a factor of 170%. For the iron oxide samples, 25% of the samples agreed within a factor of 8%, 50% agreed within a factor of 29%, 75% agreed within a factor of 63%, and all of the samples agreed within a factor of 160%. Principal components analysis (PCA) was conducted to evaluate the relationships and associations among the various potential bioavailable Fe III factors. PCA is a statistical method of identifying correlations of a large number of variables by grouping inter-related variables into "components". Results indicated that approximately 43% of the total soil data set variance was explained by the first two components. The correlations between the original variables and the components are referred to as "loadings". Thus, variables with high loadings in a particular component are associated with each other (i.e., they are intra-correlated). A listing of the variables with loadings greater than 0.45 in the first 2 components is provided in Table 4 -1 (see the list of acronyms for definitions). Component 1, which accounted for approximately 22% of the total variance in the data set, contained a number of factors that were associated with each other but not with the BAFeIII assay. Component 1 was concluded to be associated with iron as opposed to BAFeIII. Component 2, which accounted for approximately 20% of the total variance in the data set, contained several of the same variables that loaded highly into Component 1. Component 2 also contained the CDM and EPA BAFeIII assay variables and the confirmatory analyses citrate dithionite bicarbonate and ammonium oxalate extractable Fe, total Fe, and iron oxide (FeOOH)-supplemented microcosm with BrY. Component 2 was concluded to be associated with BAFeIII. These results demonstrated that positive associations exist between the BAFeIII assay and confirmatory analyses that are related to and indicative of BAFeIII.
Figure 4-3 shows, for the synthetic iron oxides, iron concentrations measured using the BAFeIII assay, microcosms, and chemical extractions, al being expressed as fractions of total iron concentrations. The results for the BAFeIII assays conducted by CDM and EPA were qualitatively similar to results of microcosms conducted with Shewanella alga BrY. Results for the chemical extractions were qualitatively different from the BAFeIII assay results. These data demonstrate the BAFeIII assay yields a more representative estimate of iron oxide bioavailability than do chemical extractions.
CDM and EPA BAFeIII assay results for 6-line ferrihydrite, lepidocrocite, and magnetite were not significantly different (p values ranged from 0.28 to 0.48). CDM and EPA BAFeIII assay results for 2-line ferrihydrite and hematite were significantly different. The CDM value was 90% greater than the EPA value for 2-line ferrihydrite (p = 0.0074). The CDM value was 56% less than the EPA value for hematite (p = 0.011). Figure 4-3 also shows the specific surface area for each oxide. Goethite, hematite, and magnetite had relatively low BET surface areas and correspondingly low BAFeIII fractions based on the BAFeIII assay. Poorly crystalline, high surface area iron oxides such as 2-line and 6-line ferrihydrite demonstrated greater BAFeIII fractions than highly crystalline, low surface area iron oxides such as magnetite, hematite, and goethite. Such a relationship between bioavailability and surface area has been demonstrated previously (Roden and Zachara, 1996) . On the other hand, lepidocrocite had a relatively low surface area and yet the highest BAFeIII fraction. Previous investigations have demonstrated that lepidocrocite has a high bioavailability even though it surface area is low (Roden, 2003; Schwertmann et al., 1986) . The relatively high bioavailability of lepidocrocite appears to be related to its crystal structure (Cooper et al., 2000; Hersman et al., 2001) . These data further indicate that factors other than surface area affect iron oxide bioavailability. Thus the direct BAFeIII bioassay yields results that are more representative of biological iron oxide reduction than are indirect chemical extractions.
A mass balance calculation on iron at the Elizabeth City Fuel Farm site was conducted to further validate the BAFeIII assay and illustrate the use of BAFeIII data. The mass balance was conducted by calculating the mass of BAFeIII originally present in the area impacted by hydrocarbons, calculating the mass of ferrous iron removed in soluble form via downgradient groundwater transport, and then comparing the two values. Comparisons of the calculated iron masses are presented in Table 4 -2. These results indicate that the BAFeIII assay did not underestimate the amount of BAFeIII iron present in the soil and thus gave a more robust BAFeIII estimate. Estimates of BAFeIII obtained using 0.5 N HCl, ammonium oxalate, and citrate dithionite bicarbonate all underestimated the mass of BAFeIII. 
Performance Criteria
Performance criteria and actual performance for the BAFeIII assay are summarized in Table 4 -3. Generally a positive association with the exception of lepidocrocite which was expected. Average RPD = 11.6 but difference between CDM and EPA results were not statistically significant.
Data Assessment
A general assessment of the data was included in Section 4.1 and a more detailed assessment is presented in the ESTCP Final Report (NAVFAC, 2005) . In summary, the following conclusions were made based on the data:
• Intra-laboratory precision was better than the relative percent deviation (RPD) criterion of 35. This precision level is adequate for the intended use. Precision deteriorated at BAFeIII concentrations less than the recommended 0.1 g/kg minimum reporting limit.
• Inter-laboratory precision was excellent and no statistically significant difference between CDM and EPA results was observed.
• Positive associations between the BAFeIII assay and confirmatory analyses were observed using principal components analysis (PCA) of soil data. These results indicate the BAFeIII assay yields results that are representative of iron bioavailability.
• An iron balance conducted on data obtained from the U.S. Coast Guard Support Station fuel farm site indicated the BAFeIII assay yields a more robust estimate of BAFeIII compared to common chemical extraction methods.
• Data obtained using synthetic iron oxides of varying surface area indicated the direct BAFeIII bioassay yields results that are more representative of biological iron oxide reduction than are indirect chemical extractions.
• The BAFeIII assay is easy to use and involves addition of weighed soil samples to preprepared test tubes, incubation, extraction, and measurement of reduced Fe II with a Hach test kit.
Technology Comparison
No other standardized and direct method exists for measurement of BAFeIII. The data demonstrated that the BAFeIII assay yields a more robust estimate of BAFeIII and yields results that are more representative of biological iron reduction than chemical extraction methods.
Cost Assessment
ESTCP guidance states that costs should be reported in this section in the recommended Federal Remediation Technologies Roundtable (FRTR) format. However, this format is primarily suited for presenting costs associated with remedial process technologies where costs need to be broken down into categories such as capital, operational and maintenance, and life cycle costs. Costs associated with purchasing and using the bioavailable iron assays do not fall into these categories, and so the FRTR format has not been used. This alternative costing approach was used in the ESTCP Final Report (NAVFAC, 2005) that was approved by ESTCP. The subsections below have been prepared to describe all costs associated with obtaining the assays and using them to analyze soil samples that have already been collected from a given site.
Cost Reporting Purchasing the Test Kit
The test kit is currently commercially available as the "Bioavailable Ferric Iron Assay" produced by New Horizons Diagnostics Inc. of Columbia, Maryland (NHD). Information about the kit and how to order can be found online at www.nhdiag.com . Orders can be placed at 800-888-5015 or 410-992-9357. As of the writing of this report, the costs of the kits were:
If only a few samples are to be analyzed, it may be most economical to have the T 0 and T 30 extracts samples analyzed for ferrous iron by a commercial analytical laboratory. Typically, this analysis can be performed for approximately $30 per sample (i.e., $60/bioavailable iron sample since both the T 0 and T 30 measurements must be conducted). A small tumbler or orbital shaker is needed for the HCl extraction steps of the assay to rotate the vials and provide mixing of the soil with the acid. This item can be purchased from most lab supply companies for approximately $250. Miscellaneous other supplies for performing the assay and ferrous iron analyses include pipettes, beakers, a small field balance (accuracy to 0.1 gram), and safety ware (gloves and glasses). An approximate cost for these supplies is $300.
Labor
The labor time required to perform the assay can be divided into three steps: The unit cost per sample is thus $212. As an alternative, commercial laboratories can also be contracted to conduct the BAFeIII analysis. Microseeps (www.microseeps.com) has quoted a price of $250 per sample for the BAFeIII analysis using the NHD test kit.
Cost Analysis
Cost Drivers Primary drivers are the test kit procurement cost, Fe II analysis cost, and labor cost not including soil sampling costs. Soil sampling costs will be the primary driver in cases where soil sampling is conducted solely for the purpose of BAFeIII analysis.
While not directly related to the cost of performing the bioavailable iron kit method, the 4-week incubation period may in some circumstances result in higher indirect costs compared to a method that gives results over a 2-week period typically associated with analytical lab turnaround times. Such indirect costs need to be considered on a case-by-case basis.
If, based on the results of analyzing initial soil samples, it is determined that additional analysis is warranted, then additional costs associated with obtaining additional soil samples would be necessary. These costs would be highly site-specific and would depend on the depth of sample needed, number of samples to be collected, and site access issues.
Sensitivity Analysis Incremental BAFeIII assay costs for soil sample collection are highly dependent on drilling method, depth, and sample collection frequency. For this sensitivity analysis both direct push and conventional (e.g., hollow-stem auger) methods were considered. For direct push it was conservatively assumed that 5 borings to a depth of 50 feet could be conducted per day and that 2 soil samples would be collected from each boring for BAFeIII analysis. At a daily drilling cost of $2,500 ($1,500 for the driller and $1,000 for engineering oversight) the incremental cost for drilling per sample is $250. For conventional drilling the incremental cost was based on a unit drilling cost of $50/foot and other parameters used for direct push. The incremental cost for drilling per sample is $1,350 ($1,560 -$212). Table 5 -2 summarized the results of this sensitivity analysis demonstrating the effect of drilling costs on the total assay cost. Often other analyses including total organic carbon, cation exchange capacity, metals, grain size distribution, and USCS classification may also be conducted on the soil samples. The incremental cost is then apportioned over the various analyses. EPA, 1998) . Enhanced anaerobic biodegradation (EAB) may also be applicable to many of these sites. BAFeIII analysis has not been conducted in the past because of difficulty, lack of standardization, and cost. The BAFeIII assay and test kit is one of several tools that can now be used to support monitored natural attenuation and enhanced anaerobic bioremediation. This test kit will benefit the DoD by making this analysis available, which will promote application of MNA and EAB at these sites. However, estimation of the DoD savings attributable to the BAFeIII test kit alone is challenging. Nevertheless, the average cost for a pump and treat operation is $9.8 million per site (Quinton et al., 1997) . If MNA is applied to 25% of the chlorinated plumes (~100 sites) at a cost of $1 million per site, the potential savings is significant.
Cost Comparison Cost Comparison
For comparison purposes, the contract analytical lab costs for conducting synthetic precipitation leaching procedure (SPLP) or toxicity characteristic leaching procedure (TCLP) analyses with zero headspace extraction (ZHE) conducted on soil samples is on the order of $90. ZHE is required to prevent oxidation of Fe II to Fe III. The extractions would be modified to use a particular chemical extractant such as 6N HCl. However, it is important to note that extraction with 6N HCl overestimates the bioavailability of many iron oxides as shown in Figure 4 -3. Analysis of extracts for total Fe and Fe II is on the order of $50. Thus the total cost is on the order of $140. There would be some labor required for labeling, packing, shipping the sample containers and filling out the chain of custody forms. This cost 30 percent less than the BAFe III assay cost. The cost of laboratory microcosms varies widely but typically is at least $10,000 and can be as high as $50,000. These costs are clearly greater than the BAFeIII assay.
Cost Basis
The analytical costs listed above are based on discussions with laboratories for performing an extraction procedure similar to the toxicity characteristic leaching procedure (TCLP) as described in 40 CFR 261/SW846 Method 1311 or synthetic precipitation leaching procedure (SPLP) as described in 40 CFR 261/SW846 Method 1312. Only the extraction acid would be modified from the standard TCLP or SPLP method. The extractant would be analyzed for ferrous and ferric iron using the phenanthroline method number 3500-Fe D (Greenberg et al., 1992) with appropriate controls for acidity of the extracts.
Implementation Issues
Cost Observations
The unit procurement cost for the BAFeIII test kit ranges from $50 to $75 depending on the number of kits purchased. The total BAFeIII analysis cost is about $210 not including soil collection costs. A BAFeIII site characterization may include anywhere from 10 to 100 analyses and thus the total analytical cost would range from $2,100 to $21,000. This cost is generally a small fraction of the total site characterization and remediation cost. Soil sample collection will comprise the majority of the cost and thus conducting multiple analyses on collected soil samples is clearly warranted.
Performance Observations
The BAFeIII test kit met all performance objectives and criteria. The fact that the relatively low surface area iron oxide lepidocrocite had a high BAFeIII concentration initially was an unexpected and interesting observation that supported the use of a direct bioassay approach in the test kit. This result deviated from the original hypothesis proposed for this demonstration/validation project, but was later determined to be consistent with current scientific data and theories on iron bioavailability. Therefore, the BAFeIII test kit was demonstrated to be a reliable, precise, easy-to-use, and cost-effective assay that yields realistic and relatively robust estimates of BAFeIII for a wide variety of soil types.
Scale-Up
The BAFeIII test kit can be used to analyze one or more samples. Scale-up is not especially relevant to this assay. However, processing of a large number of samples may warrant subcontracting the work to a commercial analytical laboratory. Larger federal laboratories or research institutions will likely be capable of easily conducting the assay in-house.
Other Significant Observations
The test kit Reagent B (i.e., lyophilized strain BrY) must be kept frozen until ready for use or it will lose viability. The test kit Reagent A is stable at room temperature.
Soil sampling should be conducted with care to minimize exposure to air and oxidation of reduced iron oxides. Use of an anaerobic glove box is not considered necessary, but saturated samples should be handled quickly and packed full into jars to minimize headspace. Preferably, the assay should be initiated as quickly as possible. Maximum sample holding times for this assay have not been determined.
The BAFeIII test kit can be procured from New Horizons Diagnostics Corporation in Columbia, Maryland. Their phone number is 1-800-888-5015 and their web address is www.nhdiag.com.
Lessons Learned
BAFeIII iron concentrations can vary laterally and vertically in impacted and background areas at a site. It is important to collect and analyze a sufficient number of samples to obtain useful results that are not obscured by heterogeneity. In general, samples should be collected from zones of greatest contaminant mass flux because it is in these zones where BAFeIII consumption will represent the most significant attenuation of contaminant mass. Samples should be collected at multiple depths along plume transects and should include several upgradient and/or crossgradient background soil samples. Duplicate analysis of samples is recommended. While none of these recommendations are hard and fast, their intent is to dissuade the user from collecting just a few samples. Such a minimalistic approach is likely to result in less useful results.
The test kit can be used to estimate the maximum BAFeIII concentration in a soil or sediment sample. Groundwater chemistry also has a significant effect on iron bioavailability (Evans, 2000; Roden and Urrutia, 2002) . Therefore, groundwater chemistry data should be considered in addition to BAFeIII assay results when making conclusions with respect to iron bioavailability.
End-User Issues
Education of regulators on the importance of BAFeIII is necessary because this parameter is not commonly measured or reported. Education of regulators on this test kit will also be necessary. End users will be able to refer regulators to this Cost and Performance Report and the ESTCP Final Report (NAVFAC, 2005) when establishing the validity of this BAFeIII test kit. Currently available models that include BAFeIII as an input parameter will also promote education about and acceptance of this assay as described further in Section 6.7.
Approach to Regulatory Compliance and Acceptance
Dr. John Wilson of the U.S. EPA has been a strong advocate of the need to quantify BAFeIII at contaminated sites. The EPA listed BAFeIII analysis as being under development in the Technical Protocol for Evaluating Natural Attenuation of Chlorinated Solvents in Ground Water (U. S. EPA, 1998). Dr. Wilson identified the BAFeIII test kit as a possible solution to this need. He was thus an important partner in this ESTCP project. Measurement of BAFeIII at sites is being conducted at increasing frequency and is becoming a regular component natural attenuation and anaerobic bioremediation evaluations. An excellent example is the fate and transport model BIOPLUME IV which includes BAFeIII as an input parameter. This model is currently being beta-tested by EPA. The fate and transport model BioRedox-MT3DMS also includes BAFeIII as an input parameter (Thompson et al. 2004) . The BAFeIII assay is also listed as an optional method to determine competition from iron reduction during EAB (AFCEE, 2004) .
BAFeIII test kit results will be used to document natural attenuation processes and to design enhanced anaerobic bioremediation remedies. In both cases the data can be used to provide regulators with a more complete and accurate technical basis for the site remedial approach. This ESTCP Cost and Performance Report will be an instrumental component of this interaction with respect to technology validation.
